Mutual of America Capital Management’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $320K | Sell |
14,729
-1,598
| -10% | -$34.7K | ﹤0.01% | 1188 |
|
|
2025
Q1 | $396K | Sell |
16,327
-657
| -4% | -$15.9K | ﹤0.01% | 1163 |
|
|
2024
Q4 | $354K | Buy |
16,984
+204
| +1% | +$4.26K | ﹤0.01% | 1230 |
|
|
2024
Q3 | $334K | Sell |
16,780
-1,664
| -9% | -$33.1K | ﹤0.01% | 1262 |
|
|
2024
Q2 | $286K | Sell |
18,444
-797
| -4% | -$12.3K | ﹤0.01% | 1304 |
|
|
2024
Q1 | $307K | Buy |
19,241
+1,701
| +10% | +$27.1K | ﹤0.01% | 1296 |
|
|
2023
Q4 | $295K | Sell |
17,540
-20
| -0.1% | -$336 | ﹤0.01% | 1303 |
|
|
2023
Q3 | $205K | Sell |
17,560
-1,483
| -8% | -$17.3K | ﹤0.01% | 1373 |
|
|
2023
Q2 | $256K | Sell |
19,043
-674
| -3% | -$9.06K | ﹤0.01% | 1341 |
|
|
2023
Q1 | $327K | Sell |
19,717
-348
| -2% | -$5.77K | ﹤0.01% | 1245 |
|
|
2022
Q4 | $373K | Buy |
20,065
+1,246
| +7% | +$23.2K | ﹤0.01% | 1201 |
|
|
2022
Q3 | $241K | Buy |
+18,819
| New | +$241K | ﹤0.01% | 1302 |
|